Cambridge Biotherapies Set to Transform Lives with New Affordable Depression Treatment
Cambridge Biotherapies™, a leader in advanced mental health treatments, proudly announces the introduction of Spravato™ (esketamine) nasal spray therapy at...
Treatment-Resistant Depression
Researchers at Fermata to Study SAINT Neuromodulation for Treatment-Resistant Major Depression
Fermata, an outpatient psychiatric center of excellence, today announced a new clinical trial to study the SAINT™ Neuromodulation System for...
